| regulation of transcription from rna polymerase ii promoter | GO:0006357 | 378 | 0.703 | |
| transcription from rna polymerase ii promoter | GO:0006366 | 368 | 0.496 | |
| snrna 3 end processing | GO:0034472 | 14 | 0.428 | |
| chromosome organization | GO:0051276 | 360 | 0.406 | |
| embryo development ending in birth or egg hatching | GO:0009792 | 152 | 0.323 | |
| imaginal disc derived appendage morphogenesis | GO:0035114 | 395 | 0.291 | |
| covalent chromatin modification | GO:0016569 | 106 | 0.288 | |
| regionalization | GO:0003002 | 416 | 0.222 | |
| histone h3 k4 methylation | GO:0051568 | 16 | 0.209 | |
| positive regulation of nitrogen compound metabolic process | GO:0051173 | 354 | 0.184 | |
| body morphogenesis | GO:0010171 | 2 | 0.174 | |
| regulation of multicellular organismal development | GO:2000026 | 414 | 0.161 | |
| head involution | GO:0008258 | 35 | 0.151 | |
| taxis | GO:0042330 | 304 | 0.150 | |
| positive regulation of transcription dna templated | GO:0045893 | 266 | 0.141 | |
| single organism behavior | GO:0044708 | 391 | 0.121 | |
| locomotory behavior | GO:0007626 | 176 | 0.118 | |
| chromosome segregation | GO:0007059 | 157 | 0.112 | |
| cell fate specification | GO:0001708 | 71 | 0.109 | |
| endodermal cell fate commitment | GO:0001711 | 3 | 0.109 | |
| nuclear division | GO:0000280 | 332 | 0.101 | |
| neuron projection guidance | GO:0097485 | 241 | 0.099 | |
| dna templated transcription elongation | GO:0006354 | 18 | 0.095 | |
| imaginal disc derived wing morphogenesis | GO:0007476 | 337 | 0.094 | |
| regulation of cell differentiation | GO:0045595 | 302 | 0.093 | |
| appendage development | GO:0048736 | 401 | 0.092 | |
| endodermal cell differentiation | GO:0035987 | 3 | 0.085 | |
| heart development | GO:0007507 | 82 | 0.083 | |
| negative regulation of nucleobase containing compound metabolic process | GO:0045934 | 261 | 0.081 | |
| forebrain development | GO:0030900 | 2 | 0.077 | |
| imaginal disc derived wing vein specification | GO:0007474 | 48 | 0.076 | |
| response to ecdysone | GO:0035075 | 34 | 0.075 | |
| stem cell maintenance | GO:0019827 | 67 | 0.075 | |
| positive regulation of biosynthetic process | GO:0009891 | 316 | 0.074 | |
| response to alcohol | GO:0097305 | 95 | 0.070 | |
| small molecule metabolic process | GO:0044281 | 305 | 0.070 | |
| cellular response to chemical stimulus | GO:0070887 | 199 | 0.069 | |
| chromatin mediated maintenance of transcription | GO:0048096 | 7 | 0.067 | |
| imaginal disc derived appendage development | GO:0048737 | 399 | 0.067 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 57 | 0.065 | |
| positive regulation of macromolecule metabolic process | GO:0010604 | 405 | 0.064 | |
| protein ubiquitination | GO:0016567 | 70 | 0.064 | |
| neurological system process | GO:0050877 | 358 | 0.062 | |
| establishment of localization in cell | GO:0051649 | 402 | 0.060 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 119 | 0.060 | |
| positive regulation of cellular biosynthetic process | GO:0031328 | 316 | 0.060 | |
| chromatin organization | GO:0006325 | 207 | 0.059 | |
| appendage morphogenesis | GO:0035107 | 397 | 0.059 | |
| morphogenesis of an epithelium | GO:0002009 | 276 | 0.059 | |
| wing disc morphogenesis | GO:0007472 | 344 | 0.058 | |
| stem cell differentiation | GO:0048863 | 117 | 0.057 | |
| positive regulation of transcription from rna polymerase ii promoter | GO:0045944 | 204 | 0.057 | |
| larval development | GO:0002164 | 104 | 0.056 | |
| peptidyl lysine modification | GO:0018205 | 57 | 0.055 | |
| positive regulation of protein metabolic process | GO:0051247 | 128 | 0.055 | |
| anterior posterior pattern specification | GO:0009952 | 136 | 0.054 | |
| embryonic organ development | GO:0048568 | 50 | 0.054 | |
| chemotaxis | GO:0006935 | 249 | 0.054 | |
| cellular protein modification process | GO:0006464 | 438 | 0.053 | |
| imaginal disc derived wing vein morphogenesis | GO:0008586 | 44 | 0.052 | |
| chromatin modification | GO:0016568 | 147 | 0.052 | |
| central nervous system development | GO:0007417 | 201 | 0.051 | |
| multi organism behavior | GO:0051705 | 175 | 0.051 | |
| tissue morphogenesis | GO:0048729 | 297 | 0.050 | |
| organelle fission | GO:0048285 | 340 | 0.049 | |
| epithelial tube morphogenesis | GO:0060562 | 88 | 0.049 | |
| endoderm formation | GO:0001706 | 3 | 0.049 | |
| response to oxygen containing compound | GO:1901700 | 200 | 0.048 | |
| zygotic determination of anterior posterior axis embryo | GO:0007354 | 27 | 0.048 | |
| meiotic nuclear division | GO:0007126 | 151 | 0.048 | |
| regulation of cellular protein metabolic process | GO:0032268 | 243 | 0.047 | |
| ncrna 3 end processing | GO:0043628 | 17 | 0.047 | |
| catabolic process | GO:0009056 | 409 | 0.045 | |
| negative regulation of response to stimulus | GO:0048585 | 258 | 0.045 | |
| response to sterol | GO:0036314 | 34 | 0.044 | |
| response to external biotic stimulus | GO:0043207 | 293 | 0.043 | |
| negative regulation of cell cycle process | GO:0010948 | 109 | 0.042 | |
| protein complex assembly | GO:0006461 | 200 | 0.042 | |
| peptidyl lysine trimethylation | GO:0018023 | 6 | 0.042 | |
| immune system process | GO:0002376 | 347 | 0.041 | |
| protein alkylation | GO:0008213 | 43 | 0.041 | |
| regulation of organelle organization | GO:0033043 | 196 | 0.040 | |
| growth | GO:0040007 | 359 | 0.040 | |
| regulation of chromatin organization | GO:1902275 | 32 | 0.037 | |
| negative regulation of rna metabolic process | GO:0051253 | 251 | 0.037 | |
| snrna processing | GO:0016180 | 14 | 0.037 | |
| regulation of catalytic activity | GO:0050790 | 185 | 0.036 | |
| immune system development | GO:0002520 | 57 | 0.036 | |
| embryonic morphogenesis | GO:0048598 | 206 | 0.036 | |
| negative regulation of developmental process | GO:0051093 | 201 | 0.036 | |
| intracellular transport | GO:0046907 | 228 | 0.035 | |
| positive regulation of nucleobase containing compound metabolic process | GO:0045935 | 332 | 0.035 | |
| positive regulation of gene expression epigenetic | GO:0045815 | 16 | 0.035 | |
| salivary gland morphogenesis | GO:0007435 | 145 | 0.035 | |
| positive regulation of rna biosynthetic process | GO:1902680 | 266 | 0.034 | |
| post embryonic appendage morphogenesis | GO:0035120 | 385 | 0.033 | |
| regulation of protein modification process | GO:0031399 | 112 | 0.033 | |
| regulation of dna templated transcription elongation | GO:0032784 | 17 | 0.033 | |
| organonitrogen compound metabolic process | GO:1901564 | 318 | 0.032 | |
| negative regulation of nucleic acid templated transcription | GO:1903507 | 240 | 0.032 | |
| vesicle mediated transport | GO:0016192 | 381 | 0.031 | |
| endocytosis | GO:0006897 | 310 | 0.031 | |
| axis specification | GO:0009798 | 167 | 0.030 | |
| positive regulation of rna metabolic process | GO:0051254 | 271 | 0.030 | |
| phagocytosis | GO:0006909 | 215 | 0.030 | |
| response to lipid | GO:0033993 | 38 | 0.029 | |
| regulation of molecular function | GO:0065009 | 217 | 0.029 | |
| cellular catabolic process | GO:0044248 | 372 | 0.029 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.029 | |
| regulation of synapse structure and activity | GO:0050803 | 128 | 0.029 | |
| respiratory system development | GO:0060541 | 213 | 0.029 | |
| histone modification | GO:0016570 | 106 | 0.028 | |
| negative regulation of transcription dna templated | GO:0045892 | 237 | 0.028 | |
| cellular response to oxygen containing compound | GO:1901701 | 79 | 0.026 | |
| response to other organism | GO:0051707 | 293 | 0.026 | |
| camera type eye development | GO:0043010 | 4 | 0.026 | |
| hemopoiesis | GO:0030097 | 46 | 0.026 | |
| positive regulation of protein modification process | GO:0031401 | 58 | 0.026 | |
| positive regulation of gene expression | GO:0010628 | 290 | 0.025 | |
| cell division | GO:0051301 | 248 | 0.025 | |
| regulation of transcription elongation from rna polymerase ii promoter | GO:0034243 | 15 | 0.024 | |
| negative regulation of macromolecule biosynthetic process | GO:0010558 | 270 | 0.024 | |
| meiotic cell cycle process | GO:1903046 | 132 | 0.024 | |
| anterior posterior axis specification | GO:0009948 | 109 | 0.024 | |
| negative regulation of cellular metabolic process | GO:0031324 | 382 | 0.024 | |
| response to biotic stimulus | GO:0009607 | 294 | 0.024 | |
| chromatin remodeling | GO:0006338 | 72 | 0.023 | |
| positive regulation of multi organism process | GO:0043902 | 40 | 0.023 | |
| sensory organ morphogenesis | GO:0090596 | 260 | 0.023 | |
| open tracheal system development | GO:0007424 | 204 | 0.022 | |
| embryonic hemopoiesis | GO:0035162 | 26 | 0.022 | |
| regulation of intracellular signal transduction | GO:1902531 | 236 | 0.022 | |
| death | GO:0016265 | 284 | 0.022 | |
| positive regulation of catalytic activity | GO:0043085 | 118 | 0.022 | |
| cell motility | GO:0048870 | 251 | 0.021 | |
| regulation of gene expression epigenetic | GO:0040029 | 128 | 0.021 | |
| dendrite development | GO:0016358 | 204 | 0.021 | |
| positive regulation of nucleic acid templated transcription | GO:1903508 | 266 | 0.021 | |
| nucleoside phosphate catabolic process | GO:1901292 | 110 | 0.021 | |
| heterocycle catabolic process | GO:0046700 | 166 | 0.021 | |
| snrna metabolic process | GO:0016073 | 14 | 0.020 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 179 | 0.020 | |
| apoptotic process | GO:0006915 | 159 | 0.020 | |
| protein complex biogenesis | GO:0070271 | 201 | 0.020 | |
| mrna splicing via spliceosome | GO:0000398 | 73 | 0.020 | |
| positive regulation of molecular function | GO:0044093 | 136 | 0.020 | |
| negative regulation of cellular macromolecule biosynthetic process | GO:2000113 | 267 | 0.020 | |
| organic substance catabolic process | GO:1901575 | 308 | 0.019 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 45 | 0.019 | |
| atp catabolic process | GO:0006200 | 38 | 0.019 | |
| dna metabolic process | GO:0006259 | 227 | 0.019 | |
| methylation | GO:0032259 | 47 | 0.019 | |
| cellular response to lipid | GO:0071396 | 20 | 0.019 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 165 | 0.019 | |
| embryonic development via the syncytial blastoderm | GO:0001700 | 148 | 0.019 | |
| mitotic nuclear division | GO:0007067 | 213 | 0.019 | |
| negative regulation of gene expression | GO:0010629 | 387 | 0.019 | |
| response to bacterium | GO:0009617 | 198 | 0.018 | |
| multicellular organismal aging | GO:0010259 | 140 | 0.018 | |
| cellular macromolecule catabolic process | GO:0044265 | 136 | 0.018 | |
| axon guidance | GO:0007411 | 233 | 0.018 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 25 | 0.018 | |
| erbb signaling pathway | GO:0038127 | 58 | 0.018 | |
| segmentation | GO:0035282 | 207 | 0.018 | |
| organic acid metabolic process | GO:0006082 | 103 | 0.018 | |
| regulation of cell cycle | GO:0051726 | 291 | 0.018 | |
| morphogenesis of follicular epithelium | GO:0016333 | 36 | 0.017 | |
| gland development | GO:0048732 | 191 | 0.017 | |
| response to ketone | GO:1901654 | 34 | 0.017 | |
| ncrna metabolic process | GO:0034660 | 43 | 0.017 | |
| nucleosome positioning | GO:0016584 | 3 | 0.017 | |
| single organism intracellular transport | GO:1902582 | 207 | 0.017 | |
| limb development | GO:0060173 | 1 | 0.017 | |
| programmed cell death | GO:0012501 | 257 | 0.017 | |
| oxoacid metabolic process | GO:0043436 | 103 | 0.017 | |
| cellular protein complex assembly | GO:0043623 | 71 | 0.017 | |
| histone h3 acetylation | GO:0043966 | 11 | 0.016 | |
| nucleoside phosphate metabolic process | GO:0006753 | 162 | 0.016 | |
| epidermal growth factor receptor signaling pathway | GO:0007173 | 58 | 0.016 | |
| homeostatic process | GO:0042592 | 199 | 0.016 | |
| nucleobase containing compound catabolic process | GO:0034655 | 165 | 0.016 | |
| positive regulation of macromolecule biosynthetic process | GO:0010557 | 283 | 0.016 | |
| meiotic cell cycle | GO:0051321 | 171 | 0.016 | |
| blastoderm segmentation | GO:0007350 | 159 | 0.016 | |
| oocyte dorsal ventral axis specification | GO:0007310 | 34 | 0.016 | |
| nuclear body organization | GO:0030575 | 6 | 0.016 | |
| defense response | GO:0006952 | 300 | 0.016 | |
| rna processing | GO:0006396 | 147 | 0.016 | |
| compound eye development | GO:0048749 | 307 | 0.016 | |
| response to organic cyclic compound | GO:0014070 | 89 | 0.016 | |
| mitotic cell cycle embryonic | GO:0045448 | 38 | 0.016 | |
| male meiosis | GO:0007140 | 52 | 0.016 | |
| peptidyl amino acid modification | GO:0018193 | 105 | 0.015 | |
| regulation of cell cycle phase transition | GO:1901987 | 130 | 0.015 | |
| protein dna complex subunit organization | GO:0071824 | 86 | 0.015 | |
| cell cell signaling involved in cell fate commitment | GO:0045168 | 210 | 0.015 | |
| cellular response to organic substance | GO:0071310 | 132 | 0.015 | |
| terminal region determination | GO:0007362 | 25 | 0.015 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 116 | 0.015 | |
| cell cycle phase transition | GO:0044770 | 140 | 0.015 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 106 | 0.015 | |
| response to organic substance | GO:0010033 | 284 | 0.015 | |
| regulation of transferase activity | GO:0051338 | 58 | 0.015 | |
| carbohydrate derivative metabolic process | GO:1901135 | 217 | 0.015 | |
| protein modification by small protein conjugation | GO:0032446 | 79 | 0.015 | |
| eye morphogenesis | GO:0048592 | 260 | 0.015 | |
| chromatin silencing | GO:0006342 | 76 | 0.014 | |
| multi organism reproductive behavior | GO:0044705 | 121 | 0.014 | |
| regulation of antimicrobial peptide biosynthetic process | GO:0002805 | 38 | 0.014 | |
| histone methylation | GO:0016571 | 40 | 0.014 | |
| single organism cellular localization | GO:1902580 | 180 | 0.014 | |
| positive regulation of multicellular organismal process | GO:0051240 | 143 | 0.014 | |
| organelle localization | GO:0051640 | 148 | 0.014 | |
| organic cyclic compound catabolic process | GO:1901361 | 168 | 0.014 | |
| single organism membrane organization | GO:0044802 | 93 | 0.014 | |
| salivary gland histolysis | GO:0035070 | 88 | 0.014 | |
| gonad development | GO:0008406 | 50 | 0.014 | |
| protein modification process | GO:0036211 | 438 | 0.014 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 242 | 0.014 | |
| negative regulation of chromatin silencing | GO:0031936 | 9 | 0.013 | |
| salivary gland cell autophagic cell death | GO:0035071 | 83 | 0.013 | |
| aggressive behavior | GO:0002118 | 63 | 0.013 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 108 | 0.013 | |
| embryonic axis specification | GO:0000578 | 107 | 0.013 | |
| aromatic compound catabolic process | GO:0019439 | 166 | 0.013 | |
| negative regulation of nitrogen compound metabolic process | GO:0051172 | 265 | 0.013 | |
| multi multicellular organism process | GO:0044706 | 123 | 0.013 | |
| protein methylation | GO:0006479 | 43 | 0.013 | |
| negative regulation of rna biosynthetic process | GO:1902679 | 240 | 0.013 | |
| peptidyl lysine methylation | GO:0018022 | 16 | 0.013 | |
| regulation of blood circulation | GO:1903522 | 21 | 0.013 | |
| nucleosome mobilization | GO:0042766 | 9 | 0.013 | |
| purine ribonucleotide metabolic process | GO:0009150 | 145 | 0.013 | |
| regulation of cellular component biogenesis | GO:0044087 | 201 | 0.013 | |
| transcription elongation from rna polymerase ii promoter | GO:0006368 | 18 | 0.013 | |
| purine nucleoside catabolic process | GO:0006152 | 112 | 0.013 | |
| axon development | GO:0061564 | 297 | 0.013 | |
| regulation of mitotic cell cycle | GO:0007346 | 190 | 0.013 | |
| negative regulation of phosphorylation | GO:0042326 | 35 | 0.012 | |
| immune response | GO:0006955 | 246 | 0.012 | |
| camera type eye morphogenesis | GO:0048593 | 2 | 0.012 | |
| eye development | GO:0001654 | 323 | 0.012 | |
| ribonucleotide catabolic process | GO:0009261 | 109 | 0.012 | |
| negative regulation of catalytic activity | GO:0043086 | 42 | 0.012 | |
| ecdysone mediated induction of salivary gland cell autophagic cell death | GO:0035072 | 12 | 0.012 | |
| neuroblast fate specification | GO:0014018 | 2 | 0.012 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 77 | 0.012 | |
| tube development | GO:0035295 | 244 | 0.012 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 119 | 0.012 | |
| cellular response to nitrogen compound | GO:1901699 | 51 | 0.012 | |
| sister chromatid segregation | GO:0000819 | 92 | 0.012 | |
| reproductive structure development | GO:0048608 | 74 | 0.011 | |
| negative regulation of cell differentiation | GO:0045596 | 143 | 0.011 | |
| cellular homeostasis | GO:0019725 | 80 | 0.011 | |
| regulation of embryonic development | GO:0045995 | 68 | 0.011 | |
| meiotic chromosome segregation | GO:0045132 | 59 | 0.011 | |
| mitotic cell cycle phase transition | GO:0044772 | 138 | 0.011 | |
| cellular ketone metabolic process | GO:0042180 | 24 | 0.011 | |
| dendrite morphogenesis | GO:0048813 | 199 | 0.011 | |
| purine containing compound catabolic process | GO:0072523 | 112 | 0.011 | |
| male genitalia development | GO:0030539 | 19 | 0.011 | |
| purine ribonucleoside catabolic process | GO:0046130 | 112 | 0.011 | |
| dorsal ventral pattern formation | GO:0009953 | 133 | 0.011 | |
| histone h4 k16 acetylation | GO:0043984 | 4 | 0.011 | |
| organophosphate catabolic process | GO:0046434 | 112 | 0.011 | |
| negative regulation of g1 s transition of mitotic cell cycle | GO:2000134 | 13 | 0.011 | |
| organic substance transport | GO:0071702 | 257 | 0.011 | |
| purine nucleotide metabolic process | GO:0006163 | 146 | 0.011 | |
| rna 3 end processing | GO:0031123 | 45 | 0.010 | |
| regulation of phosphatase activity | GO:0010921 | 3 | 0.010 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 103 | 0.010 | |
| germ line stem cell maintenance | GO:0030718 | 50 | 0.010 | |
| macromolecule methylation | GO:0043414 | 45 | 0.010 | |
| cell cycle g1 s phase transition | GO:0044843 | 31 | 0.010 | |
| anterior malpighian tubule development | GO:0061327 | 12 | 0.010 | |
